Interview with Lisa Suennen
Sequoia Capital, Thrive Capital, and Greylock Partners reportedly made a x2 ROI in just 2 weeks when Facebook acquired Instagram for $1 billion. Yes, x2 ROI in 2 weeks!
With that said, why in the hell are VC firms still interested in funding medtech companies when only 50% of all reported exits are less than $100 million and the average cost of obtaining a PMA is approximately $94 million? More importantly, what does it take for medical devices companies to get a “yes” for those VCs still interested in forking out some cash? Good questions, eh?
|Lisa Suennen is cofounder and managing member of Psilos Group. She is also a frequent contributor to MD+DI.|
Enter Lisa Suennen, Cofounder and Managing Member of Psilos Group, a healthcare-focused venture capital firm with approximately $600 million under management. She also serves as a Director on the Board of several Psilos portfolio companies, including AngioScore (Chairman), PatientSafe Solutions, OmniGuide, and VeraLight (Chairman). Lisa holds a M.A. in political science, a B.A. in political science, and a B.A. in mass communications, all from the University of California, Berkeley. Lisa is also a visiting lecturer at the U.C. Berkeley Haas School of Business.
In this interview with Lisa Suennen, we learn how and why medical device companies will need to adjust and modify their business models in order to succeed in today’s healthcare environment.
Here's What You Will Learn:
Listen to the "Medtech Business Through the Eyes of a Venture Capitalist" podcast (right click and select "Save Link As" to download the podcast).
Download the PDF action points of the "Medtech Business Through the Eyes of a Venture Capitalist" podcast.
Scott Nelson is a self-described medtech enthusiast, ambitious doer, and resident contrarian. In an effort to learn from dynamic experts in the medtech space, he founded Medsider.com. Scott has worked for some of the largest medical device companies in the world. After plenty of wins and losses, Medsider.com is the site he wished he had from the beginning.